Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zachary Rome Insider Profile
4 Followers
Zachary Rome, Director at Timber Pharmaceuticals, holds 10.24K shares in PaxMedica, Inc. (Ticker: PXMD), holds 59.70K shares in Timber Pharmaceuticals (Ticker: TMBRQ).
Zachary Rome has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Zachary Rome holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 15, 2022 - Apr 15, 2023
Return:-89.10%
The most profitable trade made by Zachary Rome
Zachary Rome's Trading History
Timber Pharmaceuticals
Apr 15, 2022
Director
Informative Buy
793.26
$596.96
PaxMedica, Inc.
Mar 14, 2024
Director
Uninformative Sell
3.38K
$3.25K
List of latest transactions for each holding click on a transaction to see Zachary Rome's performance on stock
You May Also Like
Zachary Rome insider profile FAQ
What is the percentage of profitable transactions made by Zachary Rome?
The percentage of profitable transactions made by Zachary Rome is ―.
What is the average return per transaction made by Zachary Rome?
The average return per transaction made by Zachary Rome is ―.
What stocks does Zachary Rome hold?
Zachary Rome holds: TMBRQ, PXMD stocks.
What was Zachary Rome’s latest transaction?
Zachary Rome latest transaction was an Uninformative Sell of $3.38K.
What was Zachary Rome's most profitable transaction?
Zachary Rome’s most profitable transaction was an Informative Buy of TMBRQ stock on April 15, 2022. The return on the trade was -89.10%.
What is Zachary Rome's role in Timber Pharmaceuticals?
Zachary Rome's role in Timber Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.